RBI Call 34 ROS 20.09.2024/ AT0000A33K67 /
28.06.2024 9:16:03 | Изменение+0.023 | Бид15:43:26 | Предложение15:43:26 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.398EUR | +6.13% | 0.348 Величина цены спроса: 10,000 |
0.368 Величина цены предложения: 10,000 |
ROSENBAUER INTL | 34.00 - | 20.09.2024 | Call |
GlobeNewswire
16:30
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Direct Di...
GlobeNewswire
16:25
EQIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Equinix, Inc. Investors to Secure Counsel...
GlobeNewswire
16:25
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Malibu Bo...
GlobeNewswire
16:25
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cambium N...
GlobeNewswire
16:22
Pixalate’s Q1 2024 Global SupplyChain Object (SCO) Verification Report for Connected TV (CTV) Open P...
GlobeNewswire
16:19
ALT DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Altimmune, Inc. Investors to Se...
GlobeNewswire
16:17
KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid My...
GlobeNewswire
16:15
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
GlobeNewswire
16:15
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Scotts Mi...
Newsfile Corp
16:14
LBank Exchange Listed Best Patent (BPT) on June 21, 2024, Now Achieving a Sixfold Increase in Openin...
GlobeNewswire
16:05
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AXT
GlobeNewswire
15:55
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Teladoc H...
GlobeNewswire
15:55
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Harbor Di...
GlobeNewswire
15:50
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница